Stroke prevention in atrial fibrillation: An update on current management strategies

QR Code

Stroke prevention in atrial fibrillation: An update on current management strategies

Stroke attributed to atrial fibrillation (AF) confers significant morbidity and mortality. In the past, warfarin has been the only successful stroke prevention agent available. However, it is often underutilized due to its well-known limitations, leaving many patients without adequate stroke protect...

Full description

Bibliographic Details
Main Authors:	Hall, Toby, Stanton, T., Wang, W., Ng, A.
Format:	Journal Article
Published:	2013
Online Access:	http://www.ncbi.nlm.nih.gov/pubmed/23474663 http://hdl.handle.net/20.500.11937/46115

Similar Items

Knowledge of atrial fibrillation and stroke prevention: development of questionnaire and validation of results
by: Mohamed, Sahimi, et al.
Published: (2017)

Changes in Oral Anticoagulant Prescribing for Stroke Prevention in Patients With Atrial Fibrillation
by: Admassie, E., et al.
Published: (2017)

Knowledge of Atrial Fibrillation and Stroke Prevention: Development of Questionnaire and Validation of Results
by: Sahimi, Mohamed, et al.
Published: (2016)

Early experiences with edoxaban for stroke prevention in atrial fibrillation in the Southeast Asia region
by: Bimbo Diaz, Alejandro, et al.
Published: (2023)

A comparison of dabigatran and warfarin for stroke prevention in elderly Asian population with nonvalvular atrial fibrillation: an audit of current practice in Malaysia
by: Yap, Swee Hien, et al.
Published: (2017)

Successful intravenous thrombolysis of a wake-up stroke with underlying valvular atrial fibrillation
by: Koya Kutty, Shahedah, et al.
Published: (2018)

Impact of gout on the risk of atrial fibrillation
by: Kuo, Chang-Fu, et al.
Published: (2016)

Screening for atrial fibrillation in primary care
by: Taggar, Jaspal
Published: (2017)

Bleeding-related admissions in patients with atrial fibrillation receiving antithrombotic therapy: results from the Tasmanian Atrial Fibrillation
by: Admassie, E., et al.
Published: (2017)

Thromboembolism and Mortality in the Tasmanian Atrial Fibrillation Study
by: Admassie, E., et al.
Published: (2018)

The Clinical Outcome Evaluation On The Atrial Fibrillation Patients Receiving Warfarin For Secondary Stroke Prevention In The Medication Therapy Adherence Clinic In Serdang And Seremban Hospitals
by: Mochamad Djunaedi, Mochamad Djunaedi
Published: (2016)

ENVIRONMENTAL SUSTAINABILITY APPRAISAL OF THE ATRIAL FIBRILLATION CARE PATHWAY
by: Munawar, Sana
Published: (2016)

Adherence to Oral Anticoagulants in Atrial Fibrillation: An Australian Survey
by: Obamiro, K., et al.
Published: (2018)

Anticoagulation knowledge in patients with atrial fibrillation: An Australian survey
by: Obamiro, K., et al.
Published: (2018)

Screening for atrial fibrillation in primary care: from recommendation to implementation
by: Taggar, Jaspal, et al.
Published: (2016)

The relationship between knowledge, health literacy, and adherence among patients taking oral anticoagulants for stroke thromboprophylaxis in atrial fibrillation
by: Rolls, C., et al.
Published: (2017)

The burden and implications of preoperative atrial fibrillation in Australian heart valve surgery patients
by: Russell, E., et al.
Published: (2017)

Anticoagulant use in patients with nonvalvular atrial fibrillation: has prescribing improved?
by: Bista, D., et al.
Published: (2016)

Patient Characteristics and Antithrombotic Prescribing Patterns in Patients with Atrial Fibrillation in Tasmania
by: Bista, D., et al.
Published: (2017)

Safety and efficacy of dabigatran versus warfarin in Asian patients with atrial fibrillation
by: Inche Mat, Liyana Najwa, et al.
Published: (2020)

Postoperative atrial fibrillation after isolated aortic valve replacement: A cause for concern?
by: Saxena, A., et al.
Published: (2013)

A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial Fibrillation
by: Obamiro, K., et al.
Published: (2016)

The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015
by: Alamneh, E., et al.
Published: (2017)

Atrial Fibrillation is Associated with Higher Risk of Dementia and Post-Dementia Hospitalization Mortality in Individuals Without Stroke: The Atherosclerosis Risk in Communities (ARIC) Study
by: Chen, L., et al.
Published: (2011)

Impact of periprocedural atrial fibrillation on short-term clinical outcomes following percutaneous coronary intervention
by: Chan, W., et al.
Published: (2012)

Impact of atrial fibrillation diagnosis or carotid enderterectomy requirement on outcome in patients from the triple antiplatelets for reducing dependency after ischaemic stroke (TARDIS) trial
by: Woodhouse, Lisa J., et al.
Published: (2018)

Systematic review of adherence to direct oral anticoagulants in patients with atrial fibrilation in clinical practice
by: Kubas, Mohammed Abdullah, et al.
Published: (2018)

Screening for atrial fibrillation – a cross-sectional survey of healthcare professionals in primary care
by: Taggar, Jaspal, et al.
Published: (2016)

Physical activity, obesity, weight change, and risk of atrial fibrillation the atherosclerosis risk in communities study
by: Huxley, Rachel, et al.
Published: (2014)

Atrial fibrillation and cognitive decline-the role of subclinical cerebral infarcts: The atherosclerosis risk in communities study
by: Chen, L., et al.
Published: (2014)

Atrial myxoma presenting as a cerebellar stroke
by: Azhar AH,, et al.
Published: (2011)

Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: The Atherosclerosis risk in communities study
by: Huxley, Rachel, et al.
Published: (2012)

Blood lipids and the incidence of atrial fibrillation: The multi-ethnic study of atherosclerosis and the framingham heart study
by: Alonso, A., et al.
Published: (2014)

Percentage of time in therapeutic range and proportion of thromboembolic event in nonvalvular atrial fibrillation patient on warfarin
by: Mohd, Fahmi Nazrin
Published: (2015)

Metoprolol for prophylaxis of postoperative atrial fibrillation in cardiac surgery patients: systematic review and meta-analysis
by: Mohd, Noor Norhayati, et al.
Published: (2020)

Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation
by: Huxley, Rachel, et al.
Published: (2011)

Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: The atherosclerosis risk in communities study
by: Lopez, F., et al.
Published: (2012)

Birth weight and the risk of atrial fibrillation in whites and African Americans: The atherosclerosis risk in communities (ARIC) study
by: Lawani, S., et al.
Published: (2014)

Relation of serum phosphorus levels to the incidence of atrial fibrillation (from the Atherosclerosis Risk in Communities [ARIC] study)
by: Lopez, F., et al.
Published: (2013)

High-Sensitivity Cardiac Troponin T and the Risk of Incident Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study
by: Filion, K., et al.
Published: (2011)

Cannot write session to /tmp/vufind_sessions/sess_cq42eusc9sp9gifsifqncu1so3